Proceeds to Accelerate Growth, Marketing and Expanded Capabilities in Digital Health
Recuro Health is proud to announce that the company has received additional investment through its partnerships with DeepWork Capital and GPG Ventures, bringing total raised capital to $22 million. This funding will be used to accelerate Recuro’s growth in key markets and expand commercialization of its integrated digital platform for virtual care and testing among healthcare providers, payers and patients.
Since launching in March 2021, Recuro has found alignment with partners who invest in transitioning the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes approach, as well as technologies that have critical healthcare need and a position for long-term value.
DeepWork Capital invests managed venture capital in growth-oriented, early-stage companies in the technology and life science sectors. GPG Ventures is an early-stage investment firm focused primarily on healthcare. These sponsors join existing investors as part of Recuro’s A-Round financing, including ARCH Venture Partners, OLSF Ventures, Cortado Ventures, 1843 Capital and Sage Venture Partners.
The overwhelming response to Recuro in the venture capital community demonstrates confidence in its executive leadership team and the market demand for the company’s solutions and capabilities. Early company success and market recognition was achieved by Recuro’s COVID-19 testing solution, which is one of a dozen chosen from a field of hundreds of companies to collaborate directly with the US Department of Health and Human Services, the National Institute of Health and the FDA during the pandemic.
Recuro Health exemplifies the spirit of innovation by constantly advancing its digital health technologies and delivery of integrated care, risk stratification and diagnostic solutions that improve clinical processes, outcomes, and efficiency of care. Recuro’s curated and integrated suite of digital solutions address real market challenges and impact care delivery at the intersection of quality, access and cost. From virtual primary care and behavioral telehealth to at-home testing and genetic screening, its fully customizable portfolio of solutions can be tailored to meet the needs of any population.
Read the full press release at: https://bit.ly/recuro-pr-120921
For more information about Recuro’s capabilities, contact [email protected]